Home » Newsletters » BioWorld Science

BioWorld Science

March 21, 2017

View Archived Issues

Threshold Pharmaceuticals and Molecular Templates agree to merge

NightstaRx initiates phase I/II study of gene therapy to treat X-linked retinitis pigmentosa

EURE-CART project holds launch meeting

Opiant initiates phase II trial of OPNT-001 for bulimia nervosa

BioLineRx reports partial results from phase II trial of BL-8040 for mobilization of stem cells

Actelion Pharmaceuticals presents novel antibacterial compounds

Lupin discovers new sodium channel protein type 9 subunit alpha blockers

OncoArendi Therapeutics patents chitinase and chitotriosidase-1 inhibitors

FORMA Therapeutics synthesizes new histone deacetylase 8 inhibitors

Nimbus Lakshmi presents novel TYK2 inhibitors

Tyrosine-protein kinase Mer inhibitors discovered at Dong-A Socio Holdings

Phase III MONARCH 2 breast cancer study of abemaciclib meets primary endpoint

Jazz announces promising phase III results for JZP-110 in obstructive sleep apnea

Mallinckrodt closes sale of intrathecal therapy business to Piramal Critical Care

argenx collaborates with Broteio to develop therapeutic antibody for severe autoimmune diseases

Aevi reports topline results from SAGA trial of AEVI-001 in ADHD

Bristol-Myers Squibb and CytomX expand Probody discovery collaboration

FDA sets action date to complete NDA review for latanoprostene bunod

Global Genomics announces knowPLAQUE diagnostic blood test for plaque in coronary arteries

Loxo and Ventana Medical Systems collaborate on companion diagnostic for LOXO-101

First-in-human data presented for tenofovir disoproxil orotate

Full results reported for ORION-1 trial of inclisiran in patients at cardiovascular risk

Ra Pharmaceuticals initiates phase II study of RA-101495 for PNH

Ono Pharmaceutical and X-Chem form oncology discovery collaboration

Phase II data presented for buparlisib in patients with metastatic head and neck carcinoma

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026